Back to RU Rubric Capital Management LP
ATRS
7 quarters
Position history for RURubric Capital Management LP's holdings in ANTARES PHARMA INC
As of its Q1 2022 13F, Rubric Capital Management held 10,900,000 shares of ATRS (Antares Pharma), worth $44.7M. Rubric Capital Management's 13F filings listed ATRS from Q4 2020 to Q1 2022, 6 quarterly filings. ATRS was 1.6% of Rubric Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$14.2M
Total Shares Change
-3.6M
Quarter-by-Quarter History